ArtBlood
Latest round
- Seed
Last raised
- Aug 2022
Total raised
- $0.4M
Investors
- 3
About ArtBlood
, operates as a biotechnology company that produces blood for transfusion. The company offers a cell-based in vitro blood production system used to produce various blood types, including universal donor blood. The company’s product pipeline includes products like UniArt Cell Line and DiArt Cell Line used for blood transfusions and differentiating into red blood cells of various types, including the universal O negative type.
Who invested in ArtBlood
3 investors across 2 rounds
See all investors in ArtBlood
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ArtBlood
Who invested in ArtBlood?
ArtBlood has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ArtBlood raised?
ArtBlood has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ArtBlood last raise money?
ArtBlood's most recent round on record is a Seed, in Aug 2022.
What does ArtBlood do?
, operates as a biotechnology company that produces blood for transfusion.
Where is ArtBlood headquartered?
ArtBlood is headquartered in Seoul, South Korea.
Which VCs invest in companies like ArtBlood?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at ArtBlood's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like ArtBlood? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.